NCT04973566View on ClinicalTrials.gov

A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

May 27, 2022

Study Completion Date

May 27, 2022

Conditions

Healthy

Interventions

DRUG

Nipocalimab

Nipocalimab will be administered as an IV infusion.

DRUG

Etanercept

Etanercept will be administered subcutaneously.

DRUG

Hydroxychloroquine

HCQ will be administered orally.

Trial Locations (1)

NZ 9728

PRA Health Sciences, Groningen

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT04973566 - A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants | Biotech Hunter | Biotech Hunter